Patients with haemophilia (PWH) are relatively protected from cardiovascular death. Recent
insights have shown that this is not due to less formation of atherosclerosis than in non …

Bivalirudin, a direct thrombin inhibitor, is as effective as unfractionated heparin (UFH), with
decreased bleeding in patients with acute coronary syndromes who undergo percutaneous …

Objective Anticoagulation with unfractionated heparin (UFH) in critically ill cardiac surgery
patients has several limitations, including the risk of heparin-induced thrombocytopenia. The …

Low/medium-bleeding-risk populations undergoing percutaneous coronary intervention
(PCI) show significantly less bleeding with bivalirudin (BIV) than with unfractionated heparin …

MATERIALS AND METHODS The study was conducted in accordance with the Declaration
of Helsinki [World Medical Association], Good Clinical Practice (GCP) guidelines and the …

The direct thrombin inhibitor bivalirudin has gained popularity in cardiovascular medicine
over the past decade because, in comparison with unfractionated heparin, it guarantees a …

Randomized controlled trials have shown improved short-term bleeding outcomes for
bivalirudin compared to other anticoagulant in patients undergoing percutaneous coronary …

Due to an increased life expectancy, besides hemophilia‐related comorbidity (eg
arthropathy, hepatitis C and human immunodeficiency virus infection) nonhemophilia …

В структуре заболеваемости и смертности населения основная доля на протяжении
последних десятилетий принадлежит сердечно-сосудистым заболеваниям (ССЗ). При …

В обзоре приведены литературные данные о том, какие современные
антитромботические препараты применяют для сопровождения чрескожного …